📰 Medication Guidefor News
Page 5 - Medication Guidefor News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Medication Guidefor. Real-time updates on events, politics, business and more.
November 1, 2021
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced comprehensive efficacy and safety data from the DISCOVER–2 trial of...
October 13, 2021
Full analysis of Phase 3b NOVA study provides insights on efficacy of every six-week dosing with natalizumab as compared to the approved every four-week dosingReal-world analysis shows significantly lower
April 16, 2021
Biogen Inc.: New Data at AAN 2021 from Across Biogens MS Portfolio Demonstrate Positive Impact of Treatment on People Living with Relapsing Multiple Sclerosis (natalizumab) can lead to meaningful improvements in mental and social health compared to Ocrevus (ocrelizumab) (diroximel fumarate) reinforce the treatments positive gastrointestinal tolerability profile Biogen advances leading research to help inform future patient management including new information on the clinical profile of exte...
April 7, 2021
(0) TYSABRI is a well-established high-efficacy treatment that now provides two routes of administration enabling flexibility to meet patients individual preferences and needs The subcutaneous option provides a shorter administration time and expands access to treatment for patients and physicians beyond the infusion setting The approval adds to Biogens strong MS portfolio and is part of its leading, innovative work to improve the understanding of optimal clinical outcomes as part of the long-...